Swedish pharmaceutical start-up developing medicines against asthma, psoriasis, eczema, and mastocytosis.
Mast Pharma AB is a pioneering biotechnology research company dedicated to developing innovative medicines for the treatment of asthma, eczema, psoriasis, and mastocytosis. Located in Uppsala, SE, Mast Pharma AB is committed to advancing healthcare solutions through rigorous scientific research and development.
At Mast Pharma AB, the focus is on pre-clinical development, exploring novel therapeutic pathways and creating effective treatments to improve patient outcomes. Mast Pharma AB aims to collaborate with other leading researchers and organizations to accelerate the development and availability of its pharmaceutical products.
Mast Pharma AB is poised to make significant contributions to the biotechnology landscape. The team is diligently working to complete additional company details, ensuring comprehensive information is available soon. We invite the management team at Mast Pharma AB to create a customized and exclusive company showcase and product listing on our platform, highlighting their groundbreaking work.
Other organizations in the same industry
This company is also known as